BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2325571)

  • 1. Long-term treatment with calcitriol in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
    Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF
    Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption.
    Need AG; Nordin C; Horowitz M; Morris HA
    Metabolism; 1990 Apr; 39(4 Suppl 1):53-4. PubMed ID: 2325573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
    Need AG; Morris HA; Horowitz M; Nordin BE
    Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
    Gallagher JC
    Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
    Gallagher JC; Goldgar D
    Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
    Gallagher JC
    J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
    Riggs BL; Nelson KI
    J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites.
    Caniggia A; Nuti R; Loré F; Martini G; Frediani B; Giovani S
    Osteoporos Int; 1993; 3 Suppl 1():181-5. PubMed ID: 8461554
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
    Eriksson SA; Lindgren JU
    Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.
    Tilyard M
    Metabolism; 1990 Apr; 39(4 Suppl 1):50-2. PubMed ID: 2325572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
    Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
    Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
    Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
    Tilyard MW; Spears GF; Thomson J; Dovey S
    N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
    Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
    Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol treatment is not effective in postmenopausal osteoporosis.
    Ott SM; Chesnut CH
    Ann Intern Med; 1989 Feb; 110(4):267-74. PubMed ID: 2913914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium absorption in normal and osteoporotic postmenopausal women.
    Morris HA; Need AG; Horowitz M; O'Loughlin PD; Nordin BE
    Calcif Tissue Int; 1991 Oct; 49(4):240-3. PubMed ID: 1760766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
    Dechant KL; Goa KL
    Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.